Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
Advertisement
Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, is a clinical professor at Temple University (TU) School of Pharmacy and a clinical pharmacy specialist in infectious diseases at Temple University Hospital in Philadelphia, Pennsylvania. He also is director of the PGY2 Residency in Infectious Diseases Pharmacy at TU.
Articles by Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
The US Food and Drug Administration approved imipenem-cilastatin-relebactam to treat complicated intra-abdominal infections and complicated urinary tract infections in adults with limited treatment options.
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
US Measles Cases Near 2,000 in 2025 as Multi-State Outbreaks Expand
2
Working in a Hot Zone: Building Trust With Local Communities, Addressing Gaps In Preparedness
3
CDC Awards Grant to Study Neonatal Hepatitis B Vaccination Outcomes in Guinea-Bissau
4
Vir Grants Norgine Commercial Rights to Hepatitis Delta Therapy in Europe, Australia, and New Zealand
5